1. Mollerup CL, Bollerslev J, Blichert-Toft M. Primary hyperparathyroidism: incidence and clinical and biochemical characteristics. Eur J Surg. 1994;160:485-9.

PMid:7849167

2. Valera Bestard B, Soria Dorado, MA, Piedrota Maroto G, Hidalgo Tenorio MC. Manifestaciones psiquiátricas secundarias a las principales enfermedades endocrinológicas. An Med Interna. 2003;20:206-12.

https://doi.org/10.4321/S0212-71992003000400011

PMid:12768837 

3. Sharma S, Rastogi A, Bhadada SK, Singh P, Varshney S, Behera A, et al. Prevalence and predictors of primary hyperparathiroidism. Endocr Pract. 2017;23:1311-5.

https://doi.org/10.4158/EP171759.OR

PMid:28816531 

4. Hodgson SF, Kennedy MA. Primary hyperparathyroidism, incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302:189-93.

https://doi.org/10.1056/NEJM198001243020402

PMid:7350459 

5. Ferrer MJ, Arroyo M, López C, Plá A, Hernández A, López R. Análisis descriptivo y resultados quirúrgicos del hiperparatiroidismo primario. Acta Otorrinolaringol Esp. 2002;53:773-80.

https://doi.org/10.1016/S0001-6519(02)78375-1

PMid:12658845 

6. Kollars J, Zarroug AE, Van Heerden J, Lteif A, Stavlo P, Suarez L, et al. Primary Hyperparathyroidism in Pediatric Patients. Pediatrics. 2005;115:974-80.

https://doi.org/10.1542/peds.2004-0804

PMid:15805373 

7. Mollerup CL, Bollerslev J, Blichert-Toft M. Primary hyperparathyroidism: incidence and clinical and biochemical characteristics. Eur J Surg. 1994;160:485-9.

PMid:7849167

8. Mollerup CL, Lindewald MD. Renal stones and primary hyperparathyroidism: natural history of renal stone disease after successful parathyroidectomy. World J Surg. 1999;23:173-6.

https://doi.org/10.1007/PL00013175

PMid:9880427 

9. Kollars J, Zarroug AE, Van Heerden J, Lteif A, Stavlo P, Suarez L, et al. Primary Hyperparathyroidism in Pediatric Patients. Pediatrics. 2005;115:974-80.

https://doi.org/10.1542/peds.2004-0804

PMid:15805373 

10. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005;257:6-17.

https://doi.org/10.1111/j.1365-2796.2004.01422.x

PMid:15606372 

11. Politz D, Norman J. Hyperparathyroidism in Patients Over 80: Clinical Characteristics and Their Ability to Undergo Outpatient Parathyroidectomy. Thyroid. 2007;17:333-9.

https://doi.org/10.1089/thy.2006.0259

PMid:17465863 

12. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:351-65.

https://doi.org/10.1210/jc.2008-1760

PMid:19193910 PMCid:PMC5393372

13. Lundgren E, Rastad J, Thurfjell E, Akerström G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery. 1997;121:287-94.

https://doi.org/10.1016/S0039-6060(97)90357-3

PMid:9092129 

14. Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, et al. Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:340-50.

https://doi.org/10.1210/jc.2008-1758

PMid:19193909 

15. Calvi LM, Bushinsky DA. When is it appropriate to order an ionized calcium?. J Am Soc Nephrol. 2008;19:1257-60.

https://doi.org/10.1681/ASN.2007121327

PMid:18216306 

16. Heath H 3rd, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;24;302:189-93.

https://doi.org/10.1056/NEJM198001243020402

PMid:7350459 

17. Armitage GC. Development of a classification system for periodontal disease and conditions. Ann Periodontol. 1999;4:1-6.

https://doi.org/10.1902/annals.1999.4.1.1

PMid:10863370 

18. Ishikawa I. Host responses in periodontal disease: a preview. Periodontol 2000. 2007;43:9-13.

https://doi.org/10.1111/j.1600-0757.2006.00188.x

PMid:17214832 

19. Page RC. Host response tests for diagnosing periodontal diseases. J Periodontol. 1992;63:356-66.

https://doi.org/10.1902/jop.1992.63.4s.356

PMid:1573549

20. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol. 1984;11:21-32.

https://doi.org/10.1111/j.1600-051X.1984.tb01305.x

PMid:6582072 

21. Persson RE, Hollender LG, Powell LV, MacEntee MI, Wyatt CC, Kiyak HA, et al. Assessment of periodontal conditions and systemic disease in older subjects. I. Focus on osteoporosis. J Clin Periodontol. 2002;29:796-802.

https://doi.org/10.1034/j.1600-051X.2002.290902.x

PMid:12423291 

22. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89:S159-72.

https://doi.org/10.1002/JPER.18-0006

PMid:29926952 

23. Yadalam PK, Thirukkumaran PV, Natarajan PM, Ardila CM. Light gradient boost tree classifier predictions on appendicitis with periodontal disease from biochemical and clinical parameters. Front Oral Health. 2024;5:1462873.

https://doi.org/10.3389/froh.2024.1462873

PMid:39346113 PMCid:PMC11427431

24. Silverman Jr S, Ware WH, Gillooly Jr. Dental aspects of hyperparathyroidism. Oral Surg Oral Med Oral Pathol. 1968;26:184-9.

https://doi.org/10.1016/0030-4220(68)90249-1

PMid:5242048 

25. Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther. 2008;12:157-70.

https://doi.org/10.1007/BF03256280

PMid:18510379 

26. Zhang J, Hu Y, Cai W. Bone metabolism factors in predicting the risk of osteoporosis fracture in the elderly. BMC Musculoskelet Disord. 2024;25:442.

https://doi.org/10.1186/s12891-024-07560-5

PMid:38840246 PMCid:PMC11155048

27. Sosa Henríquez M, Díez Pérez A. Parathyroid hormone in the treatment of osteoporosis. An. Med. Interna. 2007;24:87-97.

https://doi.org/10.4321/S0212-71992007000200010

PMid:17590097

28. Palla B, Burian E, Fliefel R, Otto S. Systematic review of oral manifestations related to hyperparathyroidism. Clin Oral Invest. 2018;22:1-27.

https://doi.org/10.1007/s00784-017-2124-0

PMid:28616750 

29. Sun L, Peng R. The value of integration of bone scan and targeted SPECT/CT in diagnosis of primary hyperparathyroidism with multiple bone brown tumor. Skeletal Radiol. 2023;52:2505-11.

https://doi.org/10.1007/s00256-023-04361-0

PMid:37227482 

30. Priemel M, Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25:305-12.

https://doi.org/10.1359/jbmr.090728

PMid:19594303 

31. Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperaparthyroidism. Arq Bras Endocrinol Metabol. 2010;54:106-9.

https://doi.org/10.1590/S0004-27302010000200004

PMid:20485897 PMCid:PMC3127400

32. Hounsfield GN. Computed medical imaging. J Comput Assist Tomo. 1980;4:665-74.

https://doi.org/10.1097/00004728-198010000-00017

PMid:6997341 

33. Nakasato T, Morita J, Ogawa Y. Evaluation of Hounsfield units as a predictive factor for the outcome of extracorporeal shock wave lithotripsy and stone composition. Urolithiasis. 2015;43:69-75.

https://doi.org/10.1007/s00240-014-0712-x

PMid:25139151 

34. Mascalchi M, Camiciottoli G, Diciotti S. Lung densitometry: Why, how and when. J Thorac Dis. 2017;9:3319-45.

https://doi.org/10.21037/jtd.2017.08.17

PMid:29221318 PMCid:PMC5708390